Walsh, EI;
Turner, EL;
Lane, JA;
Donovan, JL;
Neal, DE;
Hamdy, FC;
Martin, RM;
... Administrative staff, .; + view all
(2016)
Characteristics of men responding to an invitation to undergo testing for prostate cancer as part of a randomised trial.
Trials
, 17
, Article 497. 10.1186/s13063-016-1624-6.
Preview |
Text
Walsh2016_Article_CharacteristicsOfMenResponding.pdf - Published Version Download (778kB) | Preview |
Abstract
Background: Sociodemographic characteristics are associated with participating in cancer screening and trials. We compared the characteristics of those responding with those not responding to a single invitation for prostate-specific antigen (PSA) testing for prostate cancer as part of the Cluster randomised triAl of PSA testing for Prostate cancer (CAP). / Methods: Age, rurality and deprivation among 197,763 men from 271 cluster-randomised primary care centres in the UK were compared between those responding (n = 90,300) and those not responding (n = 100,953) to a prostate cancer testing invitation. / Results: There was little difference in age between responders and nonresponders. Responders were slightly more likely to come from urban rather than rural areas and were slightly less deprived than those who did not respond. / Conclusion: These data indicate similarities in age and only minor differences in deprivation and urban location between responders and nonresponders. These differences were smaller, but in the same direction as those observed in other screening trials. / Trial registration: ISRCTN92187251. Registered on 29 November 2004.
Type: | Article |
---|---|
Title: | Characteristics of men responding to an invitation to undergo testing for prostate cancer as part of a randomised trial |
Location: | England |
Open access status: | An open access version is available from UCL Discovery |
DOI: | 10.1186/s13063-016-1624-6 |
Publisher version: | https://doi.org/10.1186/s13063-016-1624-6 |
Language: | English |
Additional information: | This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
Keywords: | PSA testing, Prostate cancer, Prostate specific antigen testing, Randomised controlled trial, Screening |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Inst of Clinical Trials and Methodology UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Inst of Clinical Trials and Methodology > MRC Clinical Trials Unit at UCL |
URI: | https://discovery-pp.ucl.ac.uk/id/eprint/10091545 |
Archive Staff Only
View Item |